ANAVEX LIFE SCIENCES CORP. Deferred Tax Assets, Unrealized Currency Losses
ANAVEX LIFE SCIENCES CORP. (AVXL) had Deferred Tax Assets, Unrealized Currency Losses of $49.00 thousand as of 2023-09-30, per its 10-K filed 2023-11-27.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses · last filed 2023-11-27
- 2023-09-30: Deferred Tax Assets, Unrealized Currency Losses $49.00K.
- 2022-09-30: Deferred Tax Assets, Unrealized Currency Losses $44.00K.
- 2021-09-30: Deferred Tax Assets, Unrealized Currency Losses $62.00K.
- 2020-09-30: Deferred Tax Assets, Unrealized Currency Losses $27.00K.
| Period end | Deferred Tax Assets, Unrealized Currency Losses | Deferred Tax Assets, Unrealized Currency Losses as first filed |
|---|---|---|
| 2023-09-30 | $49.00K 10-K · filed 2023-11-27 | |
| 2022-09-30 | $44.00K 10-K · filed 2023-11-27 | |
| 2021-09-30 | $62.00K 10-K · filed 2023-11-27 | |
| 2020-09-30 | $27.00K 10-K · filed 2021-11-24 | |
| 2019-09-30 | $15.00K 10-K · filed 2020-12-28 | |
| 2018-09-30 | $16.00K 10-K · filed 2019-12-16 | -$13.00K 10-K · filed 2018-12-12 |
| 2017-09-30 | $25.00K 10-K · filed 2019-01-25 | |
| 2016-09-30 | $25.00K 10-K · filed 2019-01-25 | -$25.00K 10-K · filed 2016-12-14 |
| 2015-09-30 | $10.00K 10-K · filed 2017-12-11 | -$10.00K 10-K · filed 2015-12-29 |
| 2014-09-30 | -$23.00K 10-K · filed 2015-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |